Showing results 9 to 14 of 14
Pathological structural conversion of alpha-synuclein at the mitochondria induces neuronal toxicity Choi, Minee L.; Chappard, Alexandre; Singh, Bhanu P.; Maclachlan, Catherine; Rodrigues, Margarida; Fedotova, Evgenia; Berezhnov, Alexey, V; et al, NATURE NEUROSCIENCE, v.25, no.9, pp.1134 - 1148, 2022-09 |
Picomolar concentrations of oligomeric alpha-synuclein sensitizes TLR4 to play an initiating role in Parkinson's disease pathogenesis Hughes, Craig D.; Choi, Minee L.; Ryten, Mina; Hopkins, Lee; Drews, Anna; Botia, Juan A.; Iljina, Maria; et al, ACTA NEUROPATHOLOGICA, v.137, no.1, pp.103 - 120, 2019-01 |
Prediction of mechanistic subtypes of Parkinson's using patient-derived stem cell models D'Sa, Karishma; Evans, James R.; Virdi, Gurvir S.; Vecchi, Giulia; Adam, Alexander; Bertolli, Ottavia; Fleming, James; et al, NATURE MACHINE INTELLIGENCE, v.5, no.8, pp.933 - 946, 2023-08 |
Progressive Motor Neuron Pathology and the Role of Astrocytes in a Human Stem Cell Model of VCP-Related ALS Hall, Claire E.; Yao, Zhi; Choi, Minee; Tyzack, Giulia E.; Serio, Andrea; Luisier, Raphaelle; Harley, Jasmine; et al, CELL REPORTS, v.19, no.9, pp.1739 - 1749, 2017-05 |
Protein aggregation and calcium dysregulation are hallmarks of familial Parkinson’s disease in midbrain dopaminergic neurons Virdi, Gurvir S.; Choi, Minee L.; Evans, James R.; Yao, Zhi; Athauda, Dilan; Strohbuecker, Stephanie; Nirujogi, Raja S.; et al, NPJ PARKINSONS DISEASE, v.8, no.1, 2022-11 |
The Impact of Type 2 Diabetes in Parkinson's Disease Athauda, Dilan; Evans, James; Wernick, Anna; Virdi, Gurvir; Choi, Minee L.; Lawton, Michael; Vijiaratnam, Nirosen; et al, MOVEMENT DISORDERS, v.37, no.8, pp.1612 - 1623, 2022-08 |
Discover